Apr 29, 2024, 08:58 AM by

Apr 25, 2024, 08:17 AM by

Apr 25, 2024, 08:17 AM by

Apr 25, 2024, 08:16 AM by

Model Medicines has appointed Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor. With over 25 years of leadership experience in the life sciences industry, Dr. Aspeslet will provide strategic guidance to support the company's growth and advance its pipeline of novel therapeutics. Her appointment comes as Model Medicines announces the "AI Pharma Code," a set of criteria that includes identifying novel biology, new chemical entities, high zero-shot hit rates, low Tanimoto scores, a diverse pipeline across biology and disease, and preclinical proof of concept. Dr. Aspeslet's expertise will be invaluable to Model Medicines' mission to revolutionize drug discovery and development.

Apr 25, 2024, 06:00 AM by User Not Found

Bio-IT World | Ginkgo Bioworks has expanded its strategic partnership with Novo Nordisk; Mission Bio introduced sample multiplexing features for the company’s Tapestri Platform; PathAI announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology labs accelerate the adoption of AI and digital pathology; more.

Apr 24, 2024, 09:15 AM by

atson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range at the Water Equipment Show hosted in Telford, UK, on 16th May.

Apr 24, 2024, 09:15 AM by

Advancing diagnosis and research with an enterprise software platform

Apr 24, 2024, 09:15 AM by

Novel Concepts Medical’s case study shows improvement in a colon cancer patient with metastases in his liver and shrinkage of his tumor size after using our plant-based treatment.

Apr 24, 2024, 09:15 AM by

https://www.prnewswire.com/news-releases/community-health-network-selects-biofourmis-to-help-drive-care-at-home-outcomes-across-the-continuum-302124335.html?tc=eml_cleartime

Apr 24, 2024, 09:15 AM by

Clarapath forms strategic collaboration with Mayo Clinic to advance pathology tissue processing. Robotics, AI and automation help improve patient outcomes and solve laboratory labor shortages.

Apr 24, 2024, 09:15 AM by

https://www.prnewswire.com/news-releases/drfirst-and-patchrx-partnership-combines-medication-history-with-daily-patient-adherence-data-302124060.html?tc=eml_cleartime

Apr 24, 2024, 06:00 AM by User Not Found

Bio-IT World | Seaport Therapeutics plans to advance their Glyph platform, which leverages the lymphatic system to create new medicines building on clinically validated mechanisms and has demonstrated clinical proof-of-concept; Nectero Medical will accelerate the execution of the Phase II/III (stAAAble) trial and to support the submission of a New Drug Application with the U.S. Food and Drug Administration for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST) System; DeepCure will further develop its generative AI and physics-based engine to innovate the discovery of small molecule therapies for challenging targets; more.

Apr 23, 2024, 06:23 AM by

This brand relaunch emphasizes a focus on building emerging life science and biopharma brands with complementary client offerings as part of the larger CG Life platform.

Apr 23, 2024, 06:00 AM by User Not Found

Bio-IT World | High performance computing is enjoying an extreme vindication, said Dan Stanzione, Associate Vice President for Research at The University of Texas at Austin and Executive Director of TACC. In the opening plenary presentation at last week’s Bio-IT World Conference & Expo, Stanzione said that after years of cloud computing hype, artificial intelligence now demands traditional high performance computing architecture.

Apr 22, 2024, 09:02 AM by

Scientists are always looking for ways to develop better medications or other therapies that can help slow down the progression of the disease or improve symptoms. This might involve testing new drugs in the lab or in clinical trials with people who have Alzheimer's.

Apr 22, 2024, 09:02 AM by

Alfa Cytology has announced its pancreatic cancer research services for anticancer therapy in early preclinical stages.

Apr 19, 2024, 07:42 AM by

Alfa Cytology has announced its molecular biology services for TME research.

Apr 19, 2024, 07:42 AM by

Apr 19, 2024, 07:42 AM by

ProPharma, the world’s largest Research Consulting Organization (RCO), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, has announced that it received accreditation as a CRO partner for Medidata Rave EDC. This milestone marks a significant enhancement in ProPharma's service offering and ability to develop robust, custom electronic data collection systems for clinical research studies.

Apr 19, 2024, 06:00 AM by User Not Found

Bio-IT World | In modern medicine, biomarkers stand as pivotal indicators of biological processes or responses to therapeutic interventions, signaling a new era in clinical trial design and patient care. The driving idea behind the use of these tools is that by integrating the right biomarker information, scientists can properly select patients who are most likely to benefit from a particular therapy.